pravastatin has been researched along with estriol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Sugimoto, O; Ushiroyama, T | 1 |
| Kurachi, O; Maruo, T; Matsuo, H; Nakago, S; Oki, N; Takeuchi, K; Yamanaka, Y | 1 |
1 trial(s) available for pravastatin and estriol
| Article | Year |
|---|---|
Effects of combined estriol/pravastatin therapy on intima-media thickness of common carotid artery in hyperlipidemic postmenopausal women.
Topics: Arteriosclerosis; Carotid Artery, Common; Disease Progression; Drug Therapy, Combination; Estriol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postmenopause; Pravastatin; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2005 |
3 other study(ies) available for pravastatin and estriol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[The long-term effect of HMG-CoA reductase inhibitor to the hypercholesterolemia in the climacterium and its endocrinological change].
Topics: Adult; Climacteric; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Luteinizing Hormone; Middle Aged; Pravastatin; Testosterone | 1994 |